Viewing StudyNCT04464564



Ignite Creation Date: 2024-05-06 @ 2:55 PM
Last Modification Date: 2024-10-26 @ 1:39 PM
Study NCT ID: NCT04464564
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-05-01
First Post: 2020-07-06

Brief Title: Study to Assess the Efficacy Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients with Dementia of the Alzheimers Type
Sponsor:
Organization: Otsuka Pharmaceutical Development Commercialization Inc

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 750
Enrollment Type: ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE3
Observational Models:
Time Perspective List:
Who Masked List: